JP4463878B2 - バチルス菌を用いたセルロース結合ドメインの細胞外発現 - Google Patents

バチルス菌を用いたセルロース結合ドメインの細胞外発現 Download PDF

Info

Publication number: JP4463878B2
Authority: JP; Japan
Prior art keywords: cbd; bacillus; binding domain; cellulose binding; host cell
Prior art date: 1996-10-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP51993698A

Other languages

English (en)

Japanese (ja)

Other versions

JP2001507569A (ja

Inventor

エスケルントビョルンバズ，マズ

シューレイン，マルティン

リノヨルゲンセン，ペール

Original Assignee

ノボザイムスアクティーゼルスカブ

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-28

Filing date

1997-10-28

Publication date

2010-05-19

1997-10-28 Application filed by ノボザイムスアクティーゼルスカブ filed Critical ノボザイムスアクティーゼルスカブ

2001-06-12 Publication of JP2001507569A publication Critical patent/JP2001507569A/ja

2010-05-19 Application granted granted Critical

2010-05-19 Publication of JP4463878B2 publication Critical patent/JP4463878B2/ja

2017-10-28 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000001913 cellulose Substances 0.000 title claims abstract description 51
229920002678 cellulose Polymers 0.000 title claims abstract description 51
241000193830 Bacillus <bacterium> Species 0.000 title claims abstract description 45
230000014509 gene expression Effects 0.000 title claims description 37
108090000623 proteins and genes Proteins 0.000 claims abstract description 45
229920001184 polypeptide Polymers 0.000 claims abstract description 33
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 33
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 33
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 32
239000013598 vector Substances 0.000 claims abstract description 27
244000063299 Bacillus subtilis Species 0.000 claims abstract description 19
239000013604 expression vector Substances 0.000 claims abstract description 12
241000894006 Bacteria Species 0.000 claims abstract description 9
238000004519 manufacturing process Methods 0.000 claims abstract description 6
241000193744 Bacillus amyloliquefaciens Species 0.000 claims abstract description 4
241000194108 Bacillus licheniformis Species 0.000 claims abstract description 3
241000194107 Bacillus megaterium Species 0.000 claims abstract description 3
108020004414 DNA Proteins 0.000 claims description 41
235000014469 Bacillus subtilis Nutrition 0.000 claims description 29
108010059892 Cellulase Proteins 0.000 claims description 21
238000000034 method Methods 0.000 claims description 20
239000006228 supernatant Substances 0.000 claims description 14
230000001105 regulatory effect Effects 0.000 claims description 11
239000005090 green fluorescent protein Substances 0.000 claims description 10
241000186320 Cellulomonas fimi Species 0.000 claims description 9
241000589540 Pseudomonas fluorescens Species 0.000 claims description 8
239000003550 marker Substances 0.000 claims description 8
238000013518 transcription Methods 0.000 claims description 8
230000003197 catalytic effect Effects 0.000 claims description 7
108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 6
102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 6
241000193445 [Clostridium] stercorarium Species 0.000 claims description 5
230000008569 process Effects 0.000 claims description 5
230000035897 transcription Effects 0.000 claims description 5
230000001580 bacterial effect Effects 0.000 claims description 4
235000015097 nutrients Nutrition 0.000 claims description 4
241000894007 species Species 0.000 claims description 4
230000002103 transcriptional effect Effects 0.000 claims description 4
230000005026 transcription initiation Effects 0.000 claims description 3
230000014621 translational initiation Effects 0.000 claims description 3
241000010977 Cellvibrio japonicus Species 0.000 claims description 2
101150009206 aprE gene Proteins 0.000 claims description 2
238000012544 monitoring process Methods 0.000 claims description 2
101150013191 E gene Proteins 0.000 claims 1
102000004169 proteins and genes Human genes 0.000 abstract description 32
241000233866 Fungi Species 0.000 abstract description 4
108020001778 catalytic domains Proteins 0.000 abstract description 3
244000005700 microbiome Species 0.000 abstract description 2
210000004027 cell Anatomy 0.000 description 44
239000012634 fragment Substances 0.000 description 19
239000000539 dimer Substances 0.000 description 15
239000013612 plasmid Substances 0.000 description 15
102000004190 Enzymes Human genes 0.000 description 13
108090000790 Enzymes Proteins 0.000 description 13
241000588724 Escherichia coli Species 0.000 description 13
229940088598 enzyme Drugs 0.000 description 13
238000000224 chemical solution deposition Methods 0.000 description 12
239000002609 medium Substances 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
239000000203 mixture Substances 0.000 description 10
239000000872 buffer Substances 0.000 description 9
229940106157 cellulase Drugs 0.000 description 9
102000037865 fusion proteins Human genes 0.000 description 9
108020001507 fusion proteins Proteins 0.000 description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
239000000243 solution Substances 0.000 description 8
230000003321 amplification Effects 0.000 description 7
239000000499 gel Substances 0.000 description 7
238000003199 nucleic acid amplification method Methods 0.000 description 7
239000000047 product Substances 0.000 description 7
239000000523 sample Substances 0.000 description 7
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
239000006142 Luria-Bertani Agar Substances 0.000 description 6
108010076504 Protein Sorting Signals Proteins 0.000 description 6
239000011543 agarose gel Substances 0.000 description 6
238000000137 annealing Methods 0.000 description 6
238000004925 denaturation Methods 0.000 description 6
230000036425 denaturation Effects 0.000 description 6
125000005647 linker group Chemical group 0.000 description 6
238000000746 purification Methods 0.000 description 6
230000003248 secreting effect Effects 0.000 description 6
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
241001480714 Humicola insolens Species 0.000 description 5
125000000539 amino acid group Chemical group 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
229960005091 chloramphenicol Drugs 0.000 description 5
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 5
238000011282 treatment Methods 0.000 description 5
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
102000004157 Hydrolases Human genes 0.000 description 4
108090000604 Hydrolases Proteins 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
238000012512 characterization method Methods 0.000 description 4
238000010367 cloning Methods 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
230000004927 fusion Effects 0.000 description 4
239000007788 liquid Substances 0.000 description 4
210000001322 periplasm Anatomy 0.000 description 4
239000002002 slurry Substances 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
239000001488 sodium phosphate Substances 0.000 description 4
229910000162 sodium phosphate Inorganic materials 0.000 description 4
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 4
229920000936 Agarose Polymers 0.000 description 3
229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
241000193403 Clostridium Species 0.000 description 3
101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 3
101710166469 Endoglucanase Proteins 0.000 description 3
101710126559 Endoglucanase EG-II Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
125000003275 alpha amino acid group Chemical group 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
229960000723 ampicillin Drugs 0.000 description 3
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
238000003556 assay Methods 0.000 description 3
210000004899 c-terminal region Anatomy 0.000 description 3
235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
238000012258 culturing Methods 0.000 description 3
239000008367 deionised water Substances 0.000 description 3
229910021641 deionized water Inorganic materials 0.000 description 3
238000010494 dissociation reaction Methods 0.000 description 3
230000005593 dissociations Effects 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
229930027917 kanamycin Natural products 0.000 description 3
229960000318 kanamycin Drugs 0.000 description 3
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
229930182823 kanamycin A Natural products 0.000 description 3
230000010076 replication Effects 0.000 description 3
238000003756 stirring Methods 0.000 description 3
230000009466 transformation Effects 0.000 description 3
229920001817 Agar Polymers 0.000 description 2
108010084185 Cellulases Proteins 0.000 description 2
102000005575 Cellulases Human genes 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
239000004365 Protease Substances 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
239000008272 agar Substances 0.000 description 2
108090000637 alpha-Amylases Proteins 0.000 description 2
229910000147 aluminium phosphate Inorganic materials 0.000 description 2
-1 arabinofuranosidase Proteins 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 2
239000012228 culture supernatant Substances 0.000 description 2
238000013461 design Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000005284 excitation Effects 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
239000011521 glass Substances 0.000 description 2
239000008103 glucose Substances 0.000 description 2
230000010354 integration Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000004897 n-terminal region Anatomy 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
239000002773 nucleotide Substances 0.000 description 2
125000003729 nucleotide group Chemical group 0.000 description 2
239000008188 pellet Substances 0.000 description 2
229910000160 potassium phosphate Inorganic materials 0.000 description 2
235000011009 potassium phosphates Nutrition 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
230000007017 scission Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
239000012064 sodium phosphate buffer Substances 0.000 description 2
239000008223 sterile water Substances 0.000 description 2
239000011550 stock solution Substances 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000013638 trimer Substances 0.000 description 2
VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 1
UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
108010013043 Acetylesterase Proteins 0.000 description 1
241000222518 Agaricus Species 0.000 description 1
101100055551 Bacillus licheniformis amyS gene Proteins 0.000 description 1
241000194103 Bacillus pumilus Species 0.000 description 1
108091005658 Basic proteases Proteins 0.000 description 1
102100032487 Beta-mannosidase Human genes 0.000 description 1
241000605902 Butyrivibrio Species 0.000 description 1
101100008049 Caenorhabditis elegans cut-5 gene Proteins 0.000 description 1
241000178334 Caldicellulosiruptor Species 0.000 description 1
241000186321 Cellulomonas Species 0.000 description 1
241000863387 Cellvibrio Species 0.000 description 1
229920002101 Chitin Polymers 0.000 description 1
108010022172 Chitinases Proteins 0.000 description 1
102000012286 Chitinases Human genes 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
241000588700 Dickeya chrysanthemi Species 0.000 description 1
241000224495 Dictyostelium Species 0.000 description 1
101710106383 Disulfide bond formation protein B Proteins 0.000 description 1
241000588698 Erwinia Species 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
101710089384 Extracellular protease Proteins 0.000 description 1
241000223218 Fusarium Species 0.000 description 1
108091005973 GFP derivatives Proteins 0.000 description 1
241000193385 Geobacillus stearothermophilus Species 0.000 description 1
241000223198 Humicola Species 0.000 description 1
239000007836 KH2PO4 Substances 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
101100216056 Lactobacillus amylovorus amyL gene Proteins 0.000 description 1
241000239218 Limulus Species 0.000 description 1
241000203578 Microbispora Species 0.000 description 1
241000187708 Micromonospora Species 0.000 description 1
102100036617 Monoacylglycerol lipase ABHD2 Human genes 0.000 description 1
241000863420 Myxococcus Species 0.000 description 1
241000233892 Neocallimastix Species 0.000 description 1
241000221960 Neurospora Species 0.000 description 1
102220602029 Neutrophil elastase_R81P_mutation Human genes 0.000 description 1
241000228143 Penicillium Species 0.000 description 1
241000222385 Phanerochaete Species 0.000 description 1
241000206614 Porphyra purpurea Species 0.000 description 1
101710116318 Probable disulfide formation protein Proteins 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241001292348 Salipaludibacillus agaradhaerens Species 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
241001137870 Thermoanaerobacterium Species 0.000 description 1
241000203640 Thermomonospora Species 0.000 description 1
241000204652 Thermotoga Species 0.000 description 1
241000223259 Trichoderma Species 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
101150039703 amyL gene Proteins 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
108010055059 beta-Mannosidase Proteins 0.000 description 1
102000023732 binding proteins Human genes 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
229920006184 cellulose methylcellulose Polymers 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
229940096384 chicken egg white lysozyme Drugs 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
239000013068 control sample Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000007547 defect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
235000019797 dipotassium phosphate Nutrition 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000001506 fluorescence spectroscopy Methods 0.000 description 1
108091006047 fluorescent proteins Proteins 0.000 description 1
102000034287 fluorescent proteins Human genes 0.000 description 1
238000010230 functional analysis Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
125000003147 glycosyl group Chemical group 0.000 description 1
230000012010 growth Effects 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
230000002363 herbicidal effect Effects 0.000 description 1
239000004009 herbicide Substances 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000014726 immortalization of host cell Effects 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
235000019796 monopotassium phosphate Nutrition 0.000 description 1
101150112117 nprE gene Proteins 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
239000006174 pH buffer Substances 0.000 description 1
230000037361 pathway Effects 0.000 description 1
102000023848 polysaccharide binding proteins Human genes 0.000 description 1
108091008395 polysaccharide binding proteins Proteins 0.000 description 1
GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
230000012743 protein tagging Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
239000012264 purified product Substances 0.000 description 1
239000000700 radioactive tracer Substances 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
108010038196 saccharide-binding proteins Proteins 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
229960000268 spectinomycin Drugs 0.000 description 1
UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
239000007160 ty medium Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Images

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

JP51993698A 1996-10-28 1997-10-28 バチルス菌を用いたセルロース結合ドメインの細胞外発現 Expired - Fee Related JP4463878B2 (ja)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DK119296		1996-10-28
DK1192/96		1996-10-28
DK1426/96		1996-12-13
DK142696		1996-12-13
PCT/DK1997/000477 WO1998018905A1 (en)	1996-10-28	1997-10-28	Extracellular expression of cellulose binding domains (cbd) using bacillus

Publications (2)

Publication Number	Publication Date
JP2001507569A JP2001507569A (ja)	2001-06-12
JP4463878B2 true JP4463878B2 (ja)	2010-05-19

Family

ID=26065361

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP51993698A Expired - Fee Related JP4463878B2 (ja)	1996-10-28	1997-10-28	バチルス菌を用いたセルロース結合ドメインの細胞外発現

Country Status (8)

Country	Link
US (1)	US6060274A (de)
EP (1)	EP0975745B1 (de)
JP (1)	JP4463878B2 (de)
CN (1)	CN1183246C (de)
AT (1)	ATE386799T1 (de)
AU (1)	AU4699797A (de)
DE (1)	DE69738526T2 (de)
WO (1)	WO1998018905A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU776069B2 (en) *	1999-11-08	2004-08-26	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Process and composition for preparing a lignocellulose-based product, and the product obtained by the process
IL133134A0 (en) *	1999-11-25	2001-03-19	American Israeli Paper Mills	Improved paper products
PL1687419T3 (pl)	2003-10-28	2010-07-30	Novozymes North America Inc	Enzymy hybrydowe
US20150051373A1 (en) *	2011-12-19	2015-02-19	National Institute Of Advanced Industrial Science And Technology	Cellulose-/chitin-type polymeric light-emitting material

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5137819A (en) *	1988-07-08	1992-08-11	University Of British Columbia	Cellulose binding fusion proteins for immobilization and purification of polypeptides
US5536655A (en) *	1989-09-26	1996-07-16	Midwest Research Institute	Gene coding for the E1 endoglucanase
DK16490D0 (da) *	1990-01-19	1990-01-19	Novo Nordisk As	Enzym
DK115890D0 (da) *	1990-05-09	1990-05-09	Novo Nordisk As	Enzym
WO1993005226A1 (en) *	1991-08-29	1993-03-18	University Of British Columbia	Method for modification of polysaccharide fibres
MX9206979A (es) *	1991-12-04	1993-07-01	Novo Nordisk As	Metodo de clonacion de proteinas en levaduras
ES2264915T3 (es) *	1991-12-20	2007-02-01	Novozymes A/S	Eliminacion de esteres hidrofobicos de tejidos.
EP1431389A3 (de) *	1992-10-06	2004-06-30	Novozymes A/S	Zellulase Variante
US5496934A (en) *	1993-04-14	1996-03-05	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Nucleic acids encoding a cellulose binding domain
US5491084A (en) *	1993-09-10	1996-02-13	The Trustees Of Columbia University In The City Of New York	Uses of green-fluorescent protein
US5861271A (en) *	1993-12-17	1999-01-19	Fowler; Timothy	Cellulase enzymes and systems for their expressions
US5525193A (en) *	1994-10-26	1996-06-11	Novo Nordisk A/S	Use of monocomponent cellulase for removing inks, coatings, and toners from printed paper
IL111415A0 (en) *	1994-10-27	1994-12-29	Yeda Res & Dev	Modified cellulose-binding domain (cbd) proteins and use thereof
CA2219245A1 (en) *	1995-04-28	1996-10-31	Genencor International, Inc.	Detergents comprising cellulases
EP0877799A1 (de) *	1996-01-29	1998-11-18	Novo Nordisk A/S	Verfahren zum entschlichten zellulosehaltiger stoffe
ES2230594T3 (es) *	1996-01-29	2005-05-01	Novozymes A/S	Proceso para eliminacion o decoloracion de la suciedad o manchas de tejido celulosico.

1997
- 1997-10-28 US US08/959,212 patent/US6060274A/en not_active Expired - Lifetime
- 1997-10-28 CN CNB971991936A patent/CN1183246C/zh not_active Expired - Fee Related
- 1997-10-28 DE DE69738526T patent/DE69738526T2/de not_active Expired - Lifetime
- 1997-10-28 AU AU46997/97A patent/AU4699797A/en not_active Abandoned
- 1997-10-28 JP JP51993698A patent/JP4463878B2/ja not_active Expired - Fee Related
- 1997-10-28 AT AT97909214T patent/ATE386799T1/de not_active IP Right Cessation
- 1997-10-28 EP EP97909214A patent/EP0975745B1/de not_active Expired - Lifetime
- 1997-10-28 WO PCT/DK1997/000477 patent/WO1998018905A1/en not_active Ceased

Also Published As

Publication number	Publication date
JP2001507569A (ja)	2001-06-12
CN1183246C (zh)	2005-01-05
EP0975745B1 (de)	2008-02-20
DE69738526T2 (de)	2009-03-26
US6060274A (en)	2000-05-09
AU4699797A (en)	1998-05-22
DE69738526D1 (de)	2008-04-03
EP0975745A1 (de)	2000-02-02
CN1235635A (zh)	1999-11-17
ATE386799T1 (de)	2008-03-15
WO1998018905A1 (en)	1998-05-07

Legal Events

Date	Code	Title	Description
2004-08-05	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040715
2007-04-24	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070424
2007-08-02	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070711
2007-08-27	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070827
2007-11-15	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071023
2008-12-16	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081216
2009-03-12	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090219
2009-03-30	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090330
2009-07-02	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090611
2009-08-18	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090818
2009-12-04	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091203
2010-01-06	A911	Transfer to examiner for re-examination before appeal (zenchi)	Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100107
2010-01-12	TRDD	Decision of grant or rejection written
2010-01-20	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100119
2010-01-21	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01
2010-02-25	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100218
2010-02-26	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20130226 Year of fee payment: 3
2010-02-26	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150
2013-02-26	LAPS	Cancellation because of no payment of annual fees

Publication	Publication Date	Title
KR100200166B1 (ko)	1999-06-15	알칼리성 단백질 가수분해효소 및 그것의 제조방법
CA2639060C (en)	2017-08-22	Transgenic plants of altered morphology and the isolated arabidopsis thaliana endo-1,4-.beta.-glucanase gene, promoter and protein
CA2755417C (en)	2018-11-13	New fungal production system
CN109593126A (zh)	2019-04-09	多肽、其生产方法和用途
EP1187925B1 (de)	2005-03-30	Pektat lyase-fusion zur expression und ausscheidung von polypeptiden
JP4463878B2 (ja)	2010-05-19	バチルス菌を用いたセルロース結合ドメインの細胞外発現
KR101530077B1 (ko)	2015-06-22	키메릭 카파-카라기나제 또는 키메릭 람다-카라기나제의 유전자를 포함하는 재조합 벡터 및 재조합 미생물
US5529909A (en)	1996-06-25	Tyrosinase-activator protein fusion enzyme
US9593319B2 (en)	2017-03-14	Temperature-stable β-pyranosidase
JP2003526314A (ja)	2003-09-09	デンプン結合ドメイン（ｓｂｄ）の発現
CN105754970B (zh)	2019-07-12	一种碱性β-甘露聚糖酶及其编码基因和它们的应用
EP1861494A1 (de)	2007-12-05	Rekombinantes protein mit stärkebindungsdomäne und verwendung davon
KR100874873B1 (ko)	2008-12-19	신규한 자일라네이즈 효소 및 이를 암호화하는 유전자
KR20190037481A (ko)	2019-04-08	코리네박테리아 유래 세포고정모체를 이용한 목적단백질의 세포 표면발현 방법
CN107400665A (zh)	2017-11-28	一种定点突变的甘露聚糖酶及其应用
JPH02457A (ja)	1990-01-05	イソアミラーゼの構造遺伝子
KR101222889B1 (ko)	2013-01-17	이중프로모터를 포함하는 발현 시스템 및 그 시스템을 이용한 유전자 과다 발현 방법
CN101845427B (zh)	2012-05-30	一种嗜盐纤维素酶及其编码基因与应用
KR102088811B1 (ko)	2020-03-16	토양 메타게놈 유래 신규 알칼리성 리파아제/에스터라제 유전자 Lip-1447 및 이의 용도
CA2298068A1 (en)	1999-02-18	Plants transgenic for a cellulose binding domain with altered morphology
RU2408726C1 (ru)	2011-01-10	РЕКОМБИНАНТНЫЙ БЕЛОК Collbd-CBD, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pОС-Collbd, ШТАММ Escherichia coli - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО БЕЛКА Collbd-CBD, СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО БЕЛКА Collbd-CBD
Keadtidumrongkul et al.	2020	Overexpression of carbohydrate binding modules (CBMs) of Cellulomonas fimi glucanase B (CenB) in tobacco modifies cellulose in the cell wall and xylem cell enlargement.
JPH03240491A (ja)	1991-10-25	セルラーゼ遺伝子
CN111979260A (zh)	2020-11-24	用于表达荧光蛋白的肉葡萄球菌质粒及其构建方法和应用
CN105112388A (zh)	2015-12-02	对胰蛋白酶抗性提高的β-1,4-内切木聚糖酶及其制备方法与用途